TABLE 4
FROM:
Kallikrein gene downregulation in breast cancer
G M Yousef, G M Yacoub, M-E Polymeris, C Popalis, A Soosaipillai and E P Diamandis
BACK TO ARTICLETable 4. In silico analysis of kallikrein gene expression in normal and cancerous breast tissues and cell lines based on the EST databases
| Kallikrein | Library type | Positivity | Number of clones |
|---|---|---|---|
| KLK3 | Normal breast | 0/7 | 0 |
| Breast cancer | 1/14 | 2 | |
| KLK5 | Normal breast | 3/8 | 25 |
| Breast cancer | 1/14 | 1 | |
| KLK6 | Normal breast | 5/8 | 32 |
| Breast cancer | 1/14 | 1 | |
| KLK8 | Normal breast | 2/8 | 14 |
| Breast cancer | 1/14 | 9 | |
| KLK10 | Normal breast | 5/8 | 25 |
| Breast cancer | 1/14 | 1 | |
| KLK11 | Normal breast | 2/8 | 10 |
| Breast cancer | 0/14 | 0 | |
| KLK12 | Normal breast | 1/8 | 2 |
| Breast cancer | 0/14 | 0 |
